Alan Berezov

2.2k total citations
33 papers, 1.8k citations indexed

About

Alan Berezov is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Alan Berezov has authored 33 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Oncology and 15 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Alan Berezov's work include Monoclonal and Polyclonal Antibodies Research (15 papers), HER2/EGFR in Cancer Research (13 papers) and Immune Cell Function and Interaction (5 papers). Alan Berezov is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (15 papers), HER2/EGFR in Cancer Research (13 papers) and Immune Cell Function and Interaction (5 papers). Alan Berezov collaborates with scholars based in United States, Canada and China. Alan Berezov's co-authors include Ramachandran Murali, Hongtao Zhang, Mark I. Greene, Qiang Wang, Mark I. Greene, Geng Zhang, Jeffrey A. Drebin, Patrick J. Brennan, Emi Suzuki and Takako Mizuno and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Alan Berezov

33 papers receiving 1.7k citations

Peers

Alan Berezov

ONCOL

RNMI

IMMUN

PRM

Katherine R. Kozak United States

David V. Gold United States

Michael T. Lipari United States

Meizhen Lou Australia

Erwin R. Boghaert United States

Kendall D. Carey United States

Mathias Schmidt Germany

Xuewu Zhang China

Jordan A. Krall United States

Careen K. Tang United States

Katherine R. Kozak United States

Alan Berezov

965 ×1.0

760 ×1.1

ONCOL

674 ×1.4

RNMI

342 ×1.2

IMMUN

126 ×0.7

PRM

Citations per year, relative to Alan Berezov Alan Berezov (= 1×) peers Katherine R. Kozak

Countries citing papers authored by Alan Berezov

Since Specialization

Citations

This map shows the geographic impact of Alan Berezov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Berezov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Berezov more than expected).

Fields of papers citing papers by Alan Berezov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Berezov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Berezov. The network helps show where Alan Berezov may publish in the future.

Co-authorship network of co-authors of Alan Berezov

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Berezov. A scholar is included among the top collaborators of Alan Berezov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Berezov. Alan Berezov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Markant, Shirley L., Lourdes Adriana Esparza, Marat S. Pavlyukov, et al.. (2014). Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma. Oncogene. 34(29). 3770–3779. 49 indexed citations

Song, Xiaomin, Bin Li, Yan Xiao, et al.. (2012). Structural and Biological Features of FOXP3 Dimerization Relevant to Regulatory T Cell Function. Cell Reports. 1(6). 665–675. 80 indexed citations

Nagatomo, Izumi, Emi Suzuki, Takako Mizuno, et al.. (2012). YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14. Oncogene. 32(17). 2220–2229. 129 indexed citations

Ponde, Datta E., Zi-Fen Su, Alan Berezov, et al.. (2011). Development of anti-EGF receptor peptidomimetics (AERP) as tumor imaging agent. Bioorganic & Medicinal Chemistry Letters. 21(8). 2550–2553. 6 indexed citations

Zhou, Zhaocai, Xiulian Du, Zheng Cai, et al.. (2011). Structure of Sad1-UNC84 Homology (SUN) Domain Defines Features of Molecular Bridge in Nuclear Envelope. Journal of Biological Chemistry. 287(8). 5317–5326. 113 indexed citations

Cai, Zheng, Hongtao Zhang, Jing Liu, et al.. (2010). Targeting erbB receptors. Seminars in Cell and Developmental Biology. 21(9). 961–966. 25 indexed citations

Zhou, Zhaocai, Xiaomin Song, Alan Berezov, Bin Li, & Mark I. Greene. (2009). Structural aspects of the FOXP3 regulatory complex as an immunopharmacological target. International Immunopharmacology. 9(5). 518–520. 3 indexed citations

Berezov, Alan, et al.. (2008). BIBW-2992, a dual receptor tyrosine kinase inhibitor for the treatment of solid tumors.. PubMed. 9(12). 1336–46. 105 indexed citations

Cai, Zheng, Mark I. Greene, & Alan Berezov. (2008). Modulation of biomolecular interactions with complex-binding small molecules. Methods. 46(1). 39–46. 7 indexed citations

10.

Furuuchi, Keiji, Alan Berezov, Toru Kumagai, & Mark I. Greene. (2007). Targeted Antireceptor Therapy with Monoclonal Antibodies Leads to the Formation of Inactivated Tetrameric Forms of ErbB Receptors. The Journal of Immunology. 178(2). 1021–1029. 20 indexed citations

11.

Zhang, Hongtao, Alan Berezov, Qiang Wang, et al.. (2007). ErbB receptors: from oncogenes to targeted cancer therapies. Journal of Clinical Investigation. 117(8). 2051–2058. 454 indexed citations

12.

Masuda, Kazuyoshi, Xi Song, Alan Berezov, et al.. (2006). AHNP-streptavidin: a tetrameric bacterially produced antibody surrogate fusion protein against p185her2/neu. Oncogene. 25(59). 7740–7746. 17 indexed citations

13.

Murali, Ramachandran, Xin Cheng, Alan Berezov, et al.. (2005). Disabling TNF receptor signaling by induced conformational perturbation of tryptophan-107. Proceedings of the National Academy of Sciences. 102(31). 10970–10975. 38 indexed citations

14.

Berezov, Alan, et al.. (2005). Electron Paramagnetic Resonance and Fluorescence Studiesof the Conformation of Aspartate Aminotransferase Bound to GroEL. The Protein Journal. 24(7-8). 465–478. 2 indexed citations

15.

Wang, Qiang, Yoshihiko Hirohashi, Keiji Furuuchi, et al.. (2004). The Centrosome in Normal and Transformed Cells. DNA and Cell Biology. 23(8). 475–489. 46 indexed citations

16.

Murali, Ramachandran, Qifa Liu, Xin Cheng, et al.. (2003). Antibody like peptidomimetics as large scale immunodetection probes.. PubMed. 49(2). 209–16. 3 indexed citations

17.

Brennan, Patrick J., et al.. (2000). HER2/Neu: mechanisms of dimerization/oligomerization. Oncogene. 19(53). 6093–6101. 138 indexed citations

18.

Park, Byeong‐Woo, Hongtao Zhang, Chuan-Jin Wu, et al.. (2000). Rationally designed anti-HER2/neu peptide mimetic disables P185HER2/neu tyrosine kinases in vitro and in vivo. Nature Biotechnology. 18(2). 194–198. 155 indexed citations

19.

Roland, Jacques, Alan Berezov, Mark I. Greene, et al.. (1999). The Synthetic CD4 Exocyclic CDR3.AME(82-89) Inhibits NF-kappaB Nuclear Translocation, HIV-1 Promoter Activation, and Viral Gene Expression. DNA and Cell Biology. 18(11). 819–828. 2 indexed citations

20.

Berezov, Alan, Ana Iriarte, & Marino Martinez‐Carrion. (1996). Interaction of a Dimeric Mitochondrial Precursor with Phospholipid Vesicles: Direct Association of Each Subunit with the Membrane Is Required for Loss of Functionality. Archives of Biochemistry and Biophysics. 336(1). 173–183. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact